Company / Income Tax
Terns Pharmaceuticals, Inc. Income Tax History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$260.0K
FY2024
5-year range
$239.0K / $813.0K
FY2020-FY2024
Trend
+8.8%
vs FY2023
Sector context
#98 of 200
Health Care
What the data says
At $260,000, Terns Pharmaceuticals, Inc.'s income tax ranks #103 of 200 in the Health Care sector. Income Tax returned to growth in FY2024 after 3 years of decline, reaching $260,000.
Based on SEC 10-K filings.
$260,000 in FY2024 with a 3-year CAGR of -20.0%.
Improved from $358,000 to $260,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -20.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#103 of 200 in Health CareTop 51% of 200This company $260.0K Sector average $126.4M
▼
-99.8% below sector average
Key checks
Key Insights
- 3-year CAGR of -20.0%, indicating a declining trend.
- In FY2024, income tax increased 8.8% year-over-year.
- Ranks #98 out of 200 companies in the Health Care sector.
- Peak income tax was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 7.86 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $260.0K | +8.8% |
| FY2023 | $239.0K | -33.2% |
| FY2022 | $358.0K | -29.5% |
| FY2021 | $508.0K | -37.5% |
| FY2020 | $813.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026